Abstract

BackgroundDespite advancements in cervical cancer care, women with persistent, recurrent, or metastatic cervical cancer face difficult prognoses with limited treatment options. Recent results from clinical trials KEYNOTE-158 (NCT02628067) and KEYNOTE-826...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call